The analysts forecast global myelodysplastic syndrome market to grow at a CAGR of 9.93% during the period 2015-2019.

Myelodysplastic syndrome is a group of hematologic disorders that arise in the bone marrow and spread into the blood. The syndrome is characterized by the inability of the hematopoietic cells produced in the bone marrow to attain...